Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06014801
PHASE2/PHASE3

Low-intensity Versus Medium-intensity Continuous Kidney Replacement Therapy for Critically Ill Patients

Sponsor: Jikei University School of Medicine

View on ClinicalTrials.gov

Summary

This clinical trial aims to investigate whether the low treatment intensity (12 mL/kg/hr, low-dose hemodialysis/filtration) or the medium treatment intensity (25 mL/kg/hr, standard-dose hemodialysis/filtration) is more effective and safer for continuous renal replacement therapy in critically ill patients.

Official title: Low-Intensity Versus Medium-Intensity Continuous Kidney Replacement Therapy for Critically Ill Patients (LIMIT): a Multicenter Randomized Clinical Trial

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

400

Start Date

2023-10-30

Completion Date

2026-09

Last Updated

2024-10-15

Healthy Volunteers

No

Interventions

DRUG

Dialysate fluid, Filtration replacement fluid

Dose of continuous hemodialysis and/or hemofiltration

Locations (9)

Sendai Medical Center

Sendai, Miyagi, Japan

Osaka Medical and Pharmaceutical University Hospital

Takatsuki, Osaka, Japan

University of Fukui Hospital

Fukui, Japan

Tsuchiura Kyodo General Hospital

Ibaraki, Japan

Osaka University Hospital

Osaka, Japan

Jichi Medical University Hospital

Tochigi, Japan

Jikei University Hospital

Tokyo, Japan

Keio University Hospital

Tokyo, Japan

Wakayama Medical University Hospital

Wakayama, Japan